Company to share additional CLYM116 clinical data and plans for further development at R&D Spotlight in late summer ...
LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The club's closure comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results